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A mechanistic understanding of core cognitive processes, such as working memory, is crucial
to addressing psychiatric symptoms in brain disorders. We propose a combined psycho-
physical and biophysical account of two symptomatologically related diseases, both linked to
hypofunctional NMDARs: schizophrenia and autoimmune anti-NMDAR encephalitis. We first
quantified shared working memory alterations in a delayed-response task. In both patient
groups, we report a markedly reduced influence of previous stimuli on working memory
contents, despite preserved memory precision. We then simulated this finding with NMDAR-
dependent synaptic alterations in a microcircuit model of prefrontal cortex. Changes in
cortical excitation destabilized within-trial memory maintenance and could not account for
disrupted serial dependence in working memory. Rather, a quantitative fit between data and
simulations supports alterations of an NMDAR-dependent memory mechanism operating on
longer timescales, such as short-term potentiation.
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The NMDA receptor (NMDAR) subserves memorymechanisms at several timescales, including sustainedworking memory delay activity1,2 and different temporal
components of synaptic potentiation3–5. In addition, hypo-
function of NMDARs is linked to psychiatric disease, in parti-
cular schizophrenia6, and it possibly contributes to abnormal
working memory function in patients with schizophrenia7,8.
Indeed, reduced prefrontal NMDAR density characterizes this
disease9. Yet, the specific neural alterations by which NMDAR
hypofunction could lead to memory deficits in schizophrenia
are still under debate7,8. Here, we studied working memory
function in healthy controls, patients with schizophrenia, and
patients recovering from anti-NMDAR encephalitis (see
“Methods“ section and Supplementary Table 1). Anti-NMDAR
encephalitis is characterized by an antibody-mediated reduction
of NMDARs10, accompanied by initial psychosis and long-
lasting memory deficits11,12. The prevalence of positive symp-
toms during the early stages of the disease causes frequent
misdiagnosis as a schizophrenia spectrum disorder13,14. Here,
we tested patients that had overcome acute stages, and had
progressed to a more stabilized period with some positive
symptoms but dominated by negative and cognitive symptoms,
comparable to those in stabilized schizophrenia patients15. Due
to the parallels in neurobiology, clinical aspects, and cognition
of the two diseases, we expected working memory deficits in
anti-NMDAR encephalitis to qualitatively resemble those in
schizophrenia. This correspondence allows linking alterations
in working memory to the NMDAR in both patient groups.
We assessed memory alterations in a visuospatial delayed-
response task (Fig. 1a) on two coexisting temporal scales: single-
trial working memory precision as a proxy of active memory
maintenance during short delays, and serial dependence of
responses on previously memorized stimuli16,17 (serial biases,
Fig. 1b) as a read-out of passive information maintenance across
trials. Our results show reduced serial dependence but intact
working memory precision in both patient populations. Neural
correlates of this task have been identified in monkey prefrontal
cortex18–20, inspiring computational models that can capture key
aspects of neural dynamics and behavior18,21,22. The biophysical
detail of these models permits to investigate how NMDAR
hypofunction at different synaptic sites affects circuit dynamics
and working memory. Candidate mechanisms are a disturbed
balance between cortical excitation and inhibition (excitation/
inhibition balance), as it is observed in schizophrenia and in
studies using NMDAR antagonists (e.g., ketamine)2,6,23,24, and
alterations in NMDAR-regulated short-term synaptic potentia-
tion3–5,25. In the modeling section of this study, we systematically
test the potential of these candidate mechanisms for explaining
our behavioral findings. We conclude that a reduction in short-
term potentiation in a network model of working memory most
parsimoniously reproduces the experimentally observed memory
alterations in schizophrenia and anti-NMDAR encephalitis.
Results
Unaltered working memory precision in both patients groups.
First, we sought to identify alterations in single-trial working
memory precision, as an indication of a possible dysfunction of
activity-based memory maintenance. Meta-analyses report
mainly negative findings for delay-dependent precision impair-
ments in schizophrenia and ketamine studies7,26 (but see ref. 27).
We calculated the circular standard deviation of bias-corrected
response errors (“Methods”) as an inverse estimate of precision
for each participant and delay. Correcting for biases as a sys-
tematic source of error allowed us to estimate memory precision
independently of serial biases. For all groups, precision decreased
equally with delay (Fig. 1c), indicating spared active working
memory maintenance over short delays of up to 3 s in encepha-
litis and schizophrenia.
Patients’ memories are less biased towards previous memories.
Next, we tested whether NMDAR-related memory alterations
could be observed at intermediate timescales by measuring serial
dependence. Serial dependence is defined as a systematic shift of
responses towards previously remembered, uncorrelated stimuli16
(Fig. 1b), revealing that traces of recently processed stimuli persist
in memory circuits and are integrated with new memories.
Importantly, these attractive biases emerge over the trial’s
memory delay, indicating a dependence on memory pro-
cesses28,29. In conditions without memory requirements, only
small repulsive biases are present, possibly generated during
perceptual processing28–30. To assess NMDAR-related differences
in serial dependence, we modeled single-trial errors θe as a linear
mixed model of delay length, group, and a non-linear basis
function of the distance θd between consecutive stimuli16,29
(derivative-of-Gaussian, DoG(θd), “Methods”, Eq. (1); Supple-
mentary Fig. 1), and we assessed the significance of fixed effects
through ANOVA tables (“Methods”).
Serial dependence explained only a small fraction of single-trial
errors in working memory (conditional R2= 0.03 for the linear
model presented in Eq. (1)), reflecting its small magnitude
compared to the typical extent of response inaccuracies (Fig. 1c),
but it depended strongly on relevant task factors: In accordance
with previous results28,29, we found a dependence of attractive
bias strength on memory delay (delay × DoG(θd), (F(2,58)=
13.89, p= 1e−5). Moreover, biases differed between groups of
participants (group × DoG(θd), F(2,49)= 9.68, p= 0.0003), espe-
cially when comparing groups for different delay lengths
(group × delay × DoG(θd), F(4,58)= 8.45, p= 2e−5). Figure 1d–f
shows linear model fits and average bias curves for 0, 1, and 3 s
delays (see Supplementary Figs. 2–4 for single-subject bias curves
and fits). Groupwise linear models (Eq. (2)) allowed to assess the
delay dependence of biases within each population (delay × DoG
(θd)): For healthy controls, initially repulsive biases became
gradually more attractive with delay length (F(2,17)= 26.91, p=
6e−6; Supplementary Fig. 5). Encephalitis patients showed a
qualitatively similar, but reduced pattern (F(2,23)= 5.06, p=
0.015). In contrast, no attractive bias emerged over delay in
patients with schizophrenia (F(2,16)= 1.31, p= 0.30). Rather, a
repulsive bias dominated all delay lengths in this group (DoG(θd),
F(1,16)= 9.07, p= 0.008). Post-hoc tests and between-group
comparisons are reported in Fig. 1g–i.
Serial dependence is known to fade with increasing inter-trial
intervals (ITI)29. We controlled for ITI length by including ITI ×
DoG(θd) as a covariate in our linear model (“Methods”, Eq. (4);
Supplementary Fig. 6): For each additional second of ITI, serial
bias decreased by 0.46 ± 0.12° (mean ± s.d.). However, group
differences in serial dependence remained unchanged after
including the covariate. The timescale of serial dependence was
further defined by how many past trials influenced the current
response. We observed a much weaker delay-dependent bias
towards the penultimate trial, but there was no consistent
evidence for group differences (Supplementary Fig. 7a–c).
Antipsychotic medication does not explain group differences.
We also controlled for potential effects of antipsychotic medica-
tion in chlorpromazine equivalents (CPZ, “Methods”) in light of
significant group differences in CPZ estimates (Supplementary
Table 1), and an association of CPZ with individual serial bias
strength within groups (Supplementary Fig. 8). When including
CPZ as a covariate (“Methods”, Eq. (5)), delay-dependent biases
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still markedly differed between groups (Supplementary Fig. 8,
caption). We designed two additional analyses to demonstrate
the independence of group differences from the effect of
antipsychotic medication: First, we showed that the difference
in serial dependence persisted when we compared healthy con-
trols to the unmedicated subset of encephalitis patients (n= 12
out of 16 encephalitis patients, Supplementary Fig. 9a–f). Second,
we designed an analysis to test conservatively the group effect
once we removed all the explanatory power of CPZ: We first
fitted single-trial errors θe as a function of CPZ and its one-
and two-way interactions with delay and DoG(θd) in all subjects.
On average, CPZ in patients with schizophrenia (370.6 ± 462.4
mg day−1, mean ± s.d.) explained a reduction of 1.06° in biases in
the 3 s delay condition, and only a reduction of 0.08° in ence-
phalitis patients (with CPZ equivalents of 26.6 ± 52.7 mg day−1,
mean ± s.d.). Residuals of the linear model, now free of linear and
multiplicative effects of CPZ estimates, were fitted as a function of
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Fig. 1 Reduced working memory-dependent serial dependence in anti-NMDAR encephalitis and schizophrenia. a In each trial, subjects were to reme-
mber a stimulus that appeared for 0.25 s at a randomly chosen circular location with fixed distance from the center. Delay lengths varied randomly
between trials (0, 1 or 3 s). Subjects made a mouse click to report the remembered location and started the next trial by moving the mouse back to the
screen’s center during the inter-trial-interval (ITI). b Serial dependence is measured as a systematic shift of responses towards previous target locations.
Attractive effects depend on the distance θd between previous and current stimulus. c Precision for each subject and delay was inversely estimated as the
circular s.d. of bias-corrected error distributions (“Methods”). For longer delays, participants’ responses were less precise (delay, F(2,147)= 76.87, p < 1e
−16). There were no overall or delay-dependent group differences in precision (group, F(2,147)= 1.74, p= 0.18; group × delay, F(4,147)= 0.07, p= .99, all
p-values from ANOVA). Error bars indicate ±s.e.m. d–f, Serial dependence by group and delay length. Serial dependence is calculated as the ‘folded’ error
θe0 for different θd (dashed lines; “Methods”). Solid lines show linear model fits (“Methods”), omitting intercepts and negative values of θd. Shading, ±s.e.m.
across pooled trials from n= 19 healthy controls (ctrl), n= 17 patients with schizophrenia (schz), and n= 16 patients with anti-NMDAR encephalitis (enc).
g–i Individual (random coefficients; dots) and group estimates of serial bias strength (fixed effects; error bars indicate mean and bootstrapped 95% C.I. of
the mean) by delay. g Serial dependence was repulsive in 0 s trials (DoG(θd), F(1,52)= 12.67, p= 0.0008), independently of group (group × DoG(θd),
F(2,52)= 0.46, p= 0.63). h For 1 s trials, group differences in serial dependence emerged (group × DoG(θd), F(2,48)= 6.52, p= 0.003) between ctrl and
schz (t= 3.73, p= 7e−4, Cohen’s d= 1.28) and enc and schz (t= 2.73, p= 0.01, Cohen’s d= 0.98). i After 3 s delay, both patient groups showed reduced
biases compared to ctrl (group × DoG(θd), F(2,50)= 15.35, p= 6e−5; ctrl vs enc, t= 4.14, p= 2e−4, Cohen’s d = 1.45; ctrl vs schz, t= 6.44, p= 2e−7,
Cohen’s d= 2.21, and enc vs schz, t= 3.40, p= 0.002, Cohen’s d= 1.22). All t-tests, two-sided. In all panels, single data points show data from n= 19
healthy controls (ctrl), n= 17 patients with schizophrenia (schz), and n= 16 patients with anti-NMDAR encephalitis (enc).
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Fig. 9g–l shows that group differences in memory-dependent
biases remained marked (a reduction of 2.51° for schz, and 1.62°
for enc in the 3 s delay condition) and highly significant even after
conservatively controlling for CPZ.
Encephalitis patients’ biases increase with recovery. We did not
find correlations between individuals’ bias estimates for 3 s
delay trials and the severity of psychiatric symptoms for
encephalitis or schizophrenia patients (Supplementary Fig. 8
and Supplementary Table 1). These between-subjects analyses
were possibly underpowered, so we designed a within-subject
longitudinal assessment for n= 14 encephalitis patients that
returned for a follow-up session after 3–12 months (mean
8.5 months). As expected, clinical symptoms improved in these
patients (Supplementary Table 2) and we found that serial
dependence normalized with the patients’ recovery (Eq. (8);
Supplementary Fig. 10). Interestingly, for this subsample of
encephalitis patients, positive and general symptoms measured
in the PANSS scale correlated with serial dependence in the
follow-up session (PANSS pos, r=−0.70, C.I.= [−0.90,
−0.26], p= 0.006; PANSS gen, r=−0.62, C.I.= [−0.87,
−0.13], p= 0.02), but again not significantly in the baseline
session (PANSS pos, r=−0.38, C.I.= [−0.76, 0.19], p= 0.19;
PANSS gen, r=−0.02, C.I.= [−0.54, 0.52], p= 0.94), although
the direction of the effect was congruent between the two ses-
sions. Moreover, patients with a stronger longitudinal nor-
malization of biases improved more on the scale of positive
symptoms (PANSS pos) in the follow-up session, when com-
pared to the baseline session, r=−0.54, C.I.= [−0.83, −0.02],
p= 0.04 (Supplementary Fig. 10g; all correlations, Pearson’s r).
Together, our experimental results show no differences in
single-trial memory maintenance, but a strong reduction of
delay-dependent biases in anti-NMDAR encephalitis that
ameliorates with patients’ recovery, and a complete absence of
attractive biases in patients with schizophrenia. These findings
are not explained by ITI length, general response correlations
between trials (Supplementary Fig. 7d–f), response biases with
respect to cardinal directions (Supplementary Fig. 11), or
medication (Supplementary Fig. 8). Our conclusion is thus that
alterations at the neural circuit level, related to NMDAR
hypofunction, reduce serial dependence gradually, up to the
point of completely disrupting attraction to previous stimuli. A
prevailing idea associates NMDAR hypofunction in schizophre-
nia primarily to synapses onto GABAergic interneurons23, while
the role of NMDARs in working memory has been emphasized
in synapses between pyramidal neurons1,2,21. Alternatively,
NMDARs could be involved in mechanisms directly associated
with the generation of serial biases, such as short-term
plasticity18,22,31. To assess these mechanistic explanations
comparatively, we simulated consecutive trials of a spatial
working memory task in a spiking neural network model of
the prefrontal cortex21 (Fig. 2a). Prefrontal cortex not only holds
working memory contents in an activity-based code19,20, but also
keeps long-lasting latent (possibly synaptic) memory traces that
produce serial dependence18.
NMDAR hypofunction in a prefrontal working memory cir-
cuit. We modeled a local prefrontal circuit, composed of neurons
selective to the locations presented in the spatial working
memory task. We used a network of excitatory and inhibitory
neurons recurrently connected through AMPAR-, NMDAR- and
GABAAR-mediated synaptic transmission in which persistent
delay firing emerges from attractor dynamics (Fig. 2a, Supple-
mentary Fig. 12; “Methods”). As proposed by the previous stu-
dies18,22,31, we modeled serial dependence as an effect of short-
term plasticity that builds up at delay-active recurrent excitatory
synapses and maintains information during the ITI in a sub-
threshold stimulus representation not reflected in firing rate
selectivity (Fig. 2b, “Methods”). We implemented an associative
mechanism of short-term potentiation (STP) that is NMDAR-
dependent and upregulates glutamatergic efficacy, consistent
with a long-lasting increase in the probability of presynaptic
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Fig. 2 Ring attractor network with synaptic STP shows serial
dependence. Simulations of two consecutive working memory trials
(current trial n, previous trial n− 1) in a spiking neural network model with
bump-attractor dynamics (“Methods”). a Spike times (x-axis) of excitatory
neurons, ordered on y-axis by preferred angular location. Colored bars in a,
b mark previous and current stimulus onset times (olive) and previous
response (red). The solid orange line shows the population vector decoded
from firing rates (sliding windows of 250ms). In trial n, the active memory
representation got biased towards the memory representation in trial n− 1.
b Firing rate (black) and potentiated weight trace wij for neurons at 0°
(orange) averaged over 1,000 trials and 20 neurons centered around 0°.
Spiking activity and synaptic strength increased during trial n− 1 delay and
decreased after the response. At current stimulus onset, information about
trial n− 1 remained only in the potentiated weight trace. To facilitate
interpretation, we excluded trials for which any neuron participated in
previous and current-trial delay activity (i.e., showed firing rates >10 spikes
s−1 after stimulus onset in trial n). c, d Associativity and decay of modeled
STP. The strength of each individual synapse is determined by wij (c, middle
black trace), which is potentiated at each spike by an amount Δw that
depends on the relative spike times tj and ti of pre- and postsynaptic
neurons, respectively, and on the potentiation factor P that is chosen to
represent different strengths of STP (different colored lines in (d);
“Methods”, Eqs. (15) and (16)), and it is reduced by an amount relative to
the synaptic strength at each presynaptic spike, resulting in activity-
dependent decay (Eq. (17)).
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increase undergoes activity-dependent decay (Fig. 2c). In our
simulations, stimulus-specific potentiated synaptic traces per-
sisted through the ITI and attracted the next trial’s memory
representation progressively over the course of the delay22,31. To
mimic memory-independent repulsive biases29,30, current sti-
mulus inputs were slightly shifted away from previous stimulus
values by a fixed value31 (“Methods”). This shift represents
adaptation effects in sensory regions and is therefore not affected
by local circuit alterations in prefrontal cortex.
We assessed the effects of NMDAR dysfunction on serial
dependence at three potential synaptic sites: based on the
reported NMDAR-dependence of STP3–5, NMDAR hypofunction
would reduce the strength of STP at excitatory synapses and
disrupt delay-dependent biases (hypothesis I: reduced STP). Also,
we tested the explanatory potential of reduced NMDAR-mediated
synaptic transmission. In particular, we tested cortical disinhibi-
tion27, caused by diminished NMDAR efficacy at inhibitory
interneurons (hypothesis II: reduced gEI), and the hypofunction
of NMDARs at recurrent excitatory synapses, leading to
diminished delay activity2,32,33 (hypothesis III: reduced gEE). To
assess each of these mechanisms, we independently varied STP
strength, gEI and gEE, and we read out “behavioral responses” after
0, 1, and 3 s from population activity in our network simulations
(“Methods”). Then, we fitted a linear model to measure bias
strength in each condition (Eq. (18), Supplementary Fig. 13). We
sought to identify which mechanisms could independently
reproduce the patterns of reduced and absent biases observed
in patients, and their dependence on working memory delay
(Fig. 1).
Reduced STP but not E-I imbalance disrupts memory biases.
We found that both hypotheses I and III were qualitatively
consistent with our experimental results: NMDAR hypofunction
(whether reducing STP or gEE) reduced the strength of serial
dependence (Fig. 3a, c, orange). In contrast, hypothesis II was
discarded by our simulations: reducing gEI increased serial
dependence (Fig. 3b, orange), contrary to our experimental
results, and quickly led to network disinhibition, causing
previous-trial delay activity to spontaneously reemerge in the ITI
(Supplementary Fig. 14). Both for reduced gEI and reduced gEE,
the percentage of outlier responses (where errors θej j > 57.3°, i.e. 1
radian) quickly rose as the network lost the stability of one of its
two states (spontaneous activity for reduced gEI, and persistent
delay activity for reduced gEE, dashed vertical lines in Fig. 3b, c),
as illustrated in Supplementary Fig. 14. Moreover, we noted that
memory precision was slightly affected by all three manipulations
(Fig. 3a–c), in contrast with our behavioral findings (Fig. 1b), but
consistent with other studies with longer delays27. Delay length
and task complexity could be important factors to detect
NMDAR-related differences in memory precision.
In addition, we found that hypotheses I and III could be
disambiguated based on biases produced by the different linear
models in 0, 1, and 3 s delays (Fig. 3d–f). Even for the lowest
value of gEE within the stable network regime (Fig. 3c), attractive
biases increased with delay (Fig. 3f). While this manipulation can
qualitatively reproduce decreased delay-dependent biases in the
encephalitis group, it is incompatible with our results for patients
with schizophrenia (Fig. 1), who do not develop attractive biases
in memory trials. In contrast, reduced STP at recurrent excitatory
synapses captured a pattern of equally strong repulsive biases for
all delay lengths (Fig. 3d). Note that these findings also hold for a
network with STP (and NMDAR-dependent reductions in STP)
in inhibitory interneurons34 (Supplementary Fig. 15). Based on
our simulations, we conclude that the disruption of STP, a
mechanism operating on a longer timescale than activity-based
memory maintenance, provides a plausible explanation for
altered serial dependence as observed in schizophrenia and
anti-NMDAR encephalitis.
Discussion
In this study, we assessed working memory alterations in two
patient groups linked to NMDAR hypofunction, and hypothe-
sized that their shared clinical and neurobiological features
should be reflected in qualitatively similar behavioral patterns. In
accordance with this reasoning, we found a drastic reduction of
working memory serial dependence both in patients with anti-
NMDAR encephalitis and schizophrenia, as compared to healthy
controls. In contrast, we did not find memory maintenance def-
icits on timescales of a few seconds, suggesting that cognitive
deficits in these patients8,12 might be partly explained by the
disruption of long-lasting, inactive memory traces, and a lacking
integration of past and current memories. Our modeling results
show that simple alterations in cortical excitation (hypotheses II
and III), as proposed by current theories of NMDAR hypofunc-
tion in schizophrenia6,24,27, cannot fully explain these behavioral
findings. Instead, altered serial dependence is mechanistically
accounted for by a disruption in slower dynamics, here specified
as NMDAR-dependent associative STP (hypothesis I) that is
triggered by sustained delay activity and influences memory
representations in upcoming trials. Our results suggest that
clinical reports of short-term memory alterations in schizo-
phrenia and anti-NMDAR encephalitis could be understood in
the light of reduced synaptic potentiation25. This is consistent
with in vitro studies, which have demonstrated the dependence of
STP on specific subunit components of the NMDAR3,4, and
reduced STP in genetic mouse models of schizophrenia35.
Importantly, our modeling is not incompatible with altered cor-
tical excitatory or inhibitory tone as a result of hypofunctional
NMDARs. Rather, it states the necessity of assuming alterations
in a mechanism operating on longer timescales, such as STP. For
instance, diminished STP alongside symmetric effects on both E-
E and E-I synapses could maintain the excitation/inhibition
balance and thus stable delay activity, while interrupting passive
between-trial information maintenance.
Future studies should address the effects of pharmacological
NMDAR blockade on serial dependence. These studies could
unequivocally confirm the role of the NMDAR for trial-history
effects in working memory, and at the same time allow to ask
more specific questions: On the one hand, serial dependence
effects under different NMDAR antagonists should vary accord-
ing to how blocking specific NMDAR subunits modulates
synaptic potentiation at different timescales3. Our results cannot
address subunit specificity because anti-NMDAR encephalitis
(and possibly schizophrenia9) is associated with hypofunction of
the GluN1 subunit, which is contained in all NMDARs36,37. On
the other hand, pharmacological studies in combination with
neural recordings could reveal how trial-history representations
are affected by the blockade of NMDARs18,38. In rodents, long-
term pharmacological experiments during behavior could be
complemented with in vitro studies to assess STP directly. Finally,
pharmacological studies would clarify if the alterations in serial
dependence occur as a result of acute NMDAR hypofunction or
whether they depend on compensatory changes in STP that arise
after early, acute phases of cortical excitation/inhibition imbal-
ance in these diseases (e.g., as a long-term adjustment of the
probability of presynaptic neurotransmitter release).
We showed how working memory in the two investigated
diseases is altered in a parallel way, and how these alterations are
parsimoniously explained by manipulating a single, NMDAR-
dependent synaptic variable in our model. However, substantial
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neurobiological heterogeneity must underlie the differences in
epidemiology and longitudinal development of schizophrenia and
autoimmune anti-NMDAR encephalitis39. Under this reasoning,
we cannot exclude that distinct biological mechanisms in our two
patient groups might lead to convergent patterns of working
memory processing. For instance, our modeling shows that
encephalitis patients’ biases could also be explained qualitatively
by a reduced excitation-to-inhibition ratio in the memory circuit
(Fig. 3f), consistent with task-related fMRI BOLD activity in
ketamine33, and the effect of NMDAR antagonists on single-cell
firing rates in monkey PFC2. In contrast, we could not confirm
the findings of previous modeling work of schizophrenia, pos-
tulating that deficits in working memory precision and higher
susceptibility to distractors40,41 or alterations in probabilistic
reasoning42 could be explained by an increased excitation-to-
inhibition ratio, leading to cortical disinhibition. This mechanistic
alteration cannot replicate serial dependence deficits in schizo-
phrenia in our model (Fig. 3b, e). Reduced short-term plasticity,
in contrast, would predict reduced working memory precision
after long memory delays (Fig. 3a, see also ref. 43), and higher
susceptibility to distractors44 in line with reported behavior in
schizophrenia41, which was previously proposed to reflect an
excessive excitation-to-inhibition ratio. In addition, some incon-
gruences with previous findings might be explained by the
acuteness of the patients’ condition, with more acute or psychotic
stages being connected with patterns of disinhibition, and less
acute stages with residual alterations in synaptic plasticity, but not
cortical excitation. Alternatively, mechanisms not considered in
our model could be at play. For instance, NMDAR dysfunction
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Fig. 3 Altered STP simulates reduced serial dependence in spiking neural networks. a–c Serial dependence (orange, bias coefficients from linear model,
“Methods”) and precision (black, circular s.d. of errors) as a function of model parameters in 3 s delay trials (20,000 trials per parameter value). Vertical
dashed lines indicate transition to unstable network regimes for which more than 10% of trials were outliers ( θe
  > 57.3°, i.e., 1 radian). Shading, 95% C.I.
for regression estimates of bias coefficients in simulated responses. a Serial dependence decreased gradually when decreasing STP (potentiation factor P),
while the network remained stable for all simulated values of P. Precision changed slightly as a function of STP. b Cortical disinhibition via decreased gEI
augmented serial bias while strongly affecting precision and stability, either due to instability of persistent activity (right, Supplementary Fig. 14b), or due to
instability of spontaneous activity (left, Supplementary Fig. 14a). c Lowering recurrent cortical excitation (gEE) led to the opposite pattern, decreasing
biases. d–f Delay dependence of biases for each group, as defined by parameter values in (a–c), (respectively colored triangles). Points depict mean bias
strength (over 20,000 trials) for each parameter value. For comparison, error bars indicate 95% CI for bias strength obtained from n= 19 healthy controls
(ctrl), n= 17 patients with schizophrenia (schz), and n= 16 patients with anti-NMDAR encephalitis (enc) (reordered from Fig. 1g–i). d Lowering STP
strength reproduced the experimental data. In e, f reduction of NMDAR conductances (gEI or gEE) did not reproduce group and delay dependencies of
experimental biases. g–i Solid lines, simulated serial dependence by delay length for different values of P, indicated by colored triangles in (a) (20,000 trials
per potentiation level P). Dashed lines with error bars, serial dependence in encephalitis, schizophrenia, and healthy controls. Bias calculated as averaged
‘folded’ error θe0 for binned absolute previous-current distances θd. Shading, ±s.e.m. Compare to Supplementary Fig. 15 for a network with STP (and STP
disruptions in patients) in both E–E and E–I connections.
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history-tracking areas38 and areas that hold current working
memory contents (like prefrontal cortex), and in this way impede
the integration of previous with current memories. Note, how-
ever, that recent combined experimental and theoretical work in
primate and human prefrontal cortex shows how both past and
current memories are jointly represented in prefrontal cortex, and
how their interaction subserves serial dependence18.
Our findings advance the conceptual understanding of
working memory alterations in schizophrenia and anti-
NMDAR encephalitis, as they demonstrate a selective disrup-
tion of information carryover between trials, reflected by a
reduction of serial dependence that is robustly found in neu-
rotypical subjects17. We found several indicators of clinical
relevance for our finding. First, as anti-NMDAR encephalitis
patients recovered, their biases normalized in the direction of
healthy controls (Supplementary Fig. 10a–c). Second, the
amount of this normalization correlated across patients with
their improvement on a scale that measures positive symptoms
(Supplementary Fig. 10g), indicating a potential relation
between psychotic symptoms and reductions in serial depen-
dence. Third, both the alterations in serial dependence and the
strength of positive symptoms were higher for patients with
schizophrenia than for the anti-NMDAR encephalitis group.
Still, studies with larger sample sizes are needed to confirm the
relation of psychotic symptoms and reduced serial biases at the
subject-level, which in our study did not reach significance for
two out of three analyses in patients with schizophrenia
and anti-NMDAR encephalitis (Supplementary Fig. 8 and
“Results”).
Serial dependence could also reflect a clinically relevant
dimension which is not or only mildly related to the assessed
psychiatric scales. In this sense, it has been argued that serial
dependence could facilitate information processing in temporally
coherent real-world situations17. Alternatively, serial biases could
be the mere by-product of long-lasting cellular or synaptic
mechanisms that support memory stabilization during working
memory delays48. Our study is in line with previous findings of
reduced susceptibility to proactive interference in schizo-
phrenia49,50. However, while proactive interference is mainly
discussed in the context of cognitive control, the limited com-
plexity of our task restricts possible interpretations of reduced
between-trial interference and supports the role of reduced resi-
dual memory traces. Moreover, thanks to our task’s well-studied
single-neuron correlates18–20 and biophysical models18,19,21 and
the comparison with anti-NMDAR encephalitis patients, we
provide a specific mechanistic model of synaptic deficits leading
to reduced previous-trial interference in schizophrenia.
Interestingly, a reduction in serial dependence has recently
been reported for patients with autism51, a disease also associated
with NMDAR hypofunction52 and alterations in synaptic
potentiation25. Further, as for autism, our findings of reduced
serial dependence are compatible with normative accounts of
information processing in schizophrenia. Classic theories and
recent studies have reported an underweighting of past context,
or in Bayesian terms, learned priors, and an overweighting of
incoming perceptual information in patients with schizo-
phrenia42,53,54 and NMDAR hypofunction55. Long-lived traces of
past stimuli could serve as Bayesian priors to perception and
memory, and a disruption of STP might be regarded as a biolo-
gical implementation of a reduced usage of priors in schizo-
phrenia and anti-NMDAR encephalitis.
Methods
Experimental sample. We included n= 16 patients with anti-NMDAR ence-
phalitis (enc), n= 17 patients with schizophrenia or schizoaffective disorder (n=
12 and n= 5, respectively; schz), and n= 19 neurologically and psychiatrically
healthy control participants (ctrl), all with normal or corrected vision. Behavioral
data from n= 14 healthy controls has been included in a previous study18. Psy-
chiatric diagnoses (or the absence thereof for controls) were confirmed using the
Structured Clinical Interview for DSM IV (SCID-I)56. Patients diagnosed with anti-
NMDAR encephalitis were recruited from different centers (n= 14 in Spain, n= 1
in Germany and n= 1 in the United Kingdom) at the moment of hospital dis-
charge and completed the experiment around 5.5 months after disease onset
(median, interquartile range i.q.r.= 3.7–7.2 months). All patients fulfilled clinical
diagnostic criteria of anti-NMDAR encephalitis with confirmation of CSF IgG
antibodies against the GluN1 subunit of the NMDAR57. All subjects were tested in
our laboratory for antibodies against NMDAR in serum36 and all healthy controls
and patients with schizophrenia were seronegative. Anti-NMDAR encephalitis is
known to have a prolonged process of recovery after the acute stage of the dis-
ease58, and patients in the prolonged recovery phase still suffer from cognitive
deficits as has been previously described in cohorts with long follow-up12. All
patients were sufficiently recovered to participate in the testing procedure. Controls
and patients with schizophrenia were recruited from the Barcelona area and from
Hospital Clínic (Barcelona, Spain), respectively. Patients with schizophrenia were
tested 35.0 months after diagnosis (median, i.q.r.= 16.0–69.5 months) and were
clinically stable at the time of testing. All participants (and, in the case of minors of
age, their legal guardians) provided written informed consent and were monetarily
compensated for their time and travel expenses, as reviewed and approved by the
Research Ethics Committee of Hospital Clínic. All subjects were assessed for
psychiatric symptoms and functionality through a battery of standard tests
including the Spanish versions of the Positive and Negative Syndrome Scale
(PANSS)59, the Young Mania Rating Scale (YMRS)60, the Hamilton Depression
Rating Scale (HAM-D)61 and the Global Assessment of Functioning Scale (GAF)62.
Finally, the dose of antipsychotic medication at the moment of testing was esti-
mated as chlorpromazine equivalent (CPZ, mg day−1)63. For a demographic and
clinical overview of the populations, please refer to Supplementary Table 1.
Experimental task protocol and behavioral testing. Participants completed two
1.5 h sessions performing a visuospatial working memory task described in Fig. 1a.
In each session, participants were asked to complete 12 blocks of 48 trials. How-
ever, some participants did not complete all blocks (on average, participants
completed 1114.1 ± 134.4 trials (mean ± s.d., ctrl), 1086.0 ± 189.9 trials (enc), and
1030.6 ± 192.8 trials (schz)).
For stimulus presentation, we used Psychopy v3.1.5 on Python 2.7, running on
a 17” HP ProBook laptop. Each trial began with the presentation of a central black
fixation square on a gray background (0.5 × 0.5 cm) for 1.1 s. A single colored circle
(stimulus, diameter 1.4 cm, 1 out of 6 randomly chosen colors with equal
luminance) was then presented during 0.25 s at one of 360 randomly chosen
angular locations at a fixed radius of 4.5 cm from the center. The stimulus was
followed by a randomly chosen delay of 0 (16.67% of trials), 1 (66.67% of trials), or
3 s (16.67% of trials) in which only the fixation dot remained visible (except for 0 s
trials, where the stimulus remained visible until the participant started to move the
cursor). When the fixation dot changed to the stimulus’ color (probe), participants
were asked to respond by making a mouse click at the remembered location
(response). A white circle indicated the stimulus’ radial distance, so participants
only had to remember the angular position. After the response, the cursor had to be
moved back to the fixation dot to start a new trial (ITI). Participants were
instructed to maintain fixation during the fixation period, stimulus presentation,
and memory delay and were free to move their eyes during response and when
returning the cursor to the fixation dot.
Error and serial dependence analysis. Response errors θen in trial n were mea-
sured as the angular distance between response and target. To exclude errors due to
guessing or motor imprecision, we only analyzed responses within an angular
distance of 1 radian and a radial distance of 2.25 cm from the stimulus. Further, we
excluded trials in which the time of response initiation exceeded 3 s, and trials for
which the time between the previous trial’s response probe and the current trial’s
stimulus presentation exceeded 5 s. In total, 2.6 ± 4.2% (mean ± s.d., ctrl), 4.8 ±
6.9% (enc) and 7.5 ± 9.6% (schz) of trials per participant were rejected (but only
0.1 ± 0.2% (ctrl), 0.4 ± 0.5% (enc) and 0.6 ± 0.7% (schz) of trials were excluded due
to angular response errors).
We then measured serial dependence as the error in the current trial as a
function of the circular distance between the previous and the current trial’s target
location. Figure 1c–e depict ‘folded’ serial dependence: We multiplied trial-wise




n ¼ θen  sign θdn
 
, and
then binned data based on absolute values jθdnj. Errors θe0n were then averaged for
each jθdnj in sliding windows with size π/3 in steps of π/30. Positive mean folded
errors should be interpreted as attraction towards the previous stimulus and
negative mean folded errors as repulsion away from the previous location. In all
figures including bias curves, s.e.m. are calculated across pooled trials from all
subjects for each group and delay. For visualization, all values were transformed
from radians to angular degrees.
Linear (mixed) models. We modeled signed errors θenm in trial n and subject m
using linear mixed models that included the dummy-coded variables group (ctrl,
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enc or schz) and delay (0, 1, or 3 s), and a nonlinear function of previous-current
stimulus distance θdnm , DoG(θ
d
nm), which has been used for modeling serial
dependence16,29. DoG(θdnm) is the normalized first derivative of a Gaussian with
fixed location hyperparameter μ= 0. Its scale parameter σ was determined using
cross-validation as explained below (see also Supplementary Fig. 1). Our main
linear model is:
θenm ¼ β0 þ β1;ggroupnm þ β2;ddelaynm  β3DoGðθdnmÞ
þ β4;g;dgroupnmdelaynm  β5;ggroupnmDoGðθdnmÞ
 β6;ddelaynmDoGðθdnmÞ  β7;g;dgroupnmdelaynmDoGðθdnmÞ
þ γ0;m  γ1;mDoGðθdnmÞ  γ2;m;ddelaynmDoGðθdnmÞ þ εnm
ð1Þ
β coefficients estimate fixed, and γ coefficients random effects. Coefficient sub-
scripts g and d denote that a separate coefficient was estimated for different values
of dummy-coded variables group or delay, respectively, resulting in a total of 18 β
coefficients for Eq. (1). Coefficient subscript m denotes that a separate coefficient
was estimated for each subject. Bias strength for a certain condition can then be
read out as the sum of coefficients of all terms containing DoG(θdnm) and the
dependence of bias strength on other variables is assessed by evaluating the sig-
nificance of interaction terms containing DoG(θdnm) and the relevant variable. To
measure response precision, bias-corrected response errors were defined as linear
model residuals εnm from Eq. (1). For each subject and delay, inverse response
precision was then measured as the circular s.d. of εnm.
Group- (Eq. (2), Supplementary Fig. 5) and delay-wise (Eq. (3), Fig. 1g–i) linear
models were defined as:
θenm ¼ β0 þ β1;ddelaynm  β2DoGðθdnmÞ  β3;ddelaynmDoGðθdnmÞ
þ γ0;m  γ1;mDoGðθdnmÞ  γ2;m;ddelaynmDoGðθdnmÞ þ εnm
ð2Þ
θenm ¼ β0 þ β1;ggroupnm  β2DoGðθdnmÞ  β3;ggroupnmDoGðθdnmÞ
þ γ0;m  γ1;mDoGðθdnmÞ þ εnm
ð3Þ
The effect of covariates ITI length (Eq. (4)) and CPZ equivalent (Eq. (5)) were
assessed as:
θenm ¼ β0 þ β1;ggroupnm þ β2;ddelaynm  β3DoGðθdnmÞ
þ β4;g;dgroupnmdelaynm  β5;ggroupnmDoGðθdnmÞ
 β6;ddelaynmDoGðθdnmÞ  β7;g;dgroupnmdelaynmDoGðθdnmÞ
 β8ITInmDoGðθdnmÞ þ γ0;m  γ1;mDoGðθdnmÞ
 γ2;m;ddelaynmDoGðθdnmÞ þ εnm
ð4Þ
θenm ¼ β0 þ β1;ggroupnm þ β2;ddelaynm  β3DoGðθdnmÞ
þ β4;g;dgroupnmdelaynm  β5;ggroupnmDoGðθdnmÞ
 β6;ddelaynmDoGðθdnmÞ  β7;g;dgroupnmdelaynmDoGðθdnmÞ
 β8;dCPZnmdelaynmDoGðθdnmÞ þ γ0;m  γ1;mDoGðθdnmÞ
 γ2;m;ddelaynmDoGðθdnmÞ þ εnm
ð5Þ
Further, a conservative estimate of group effects when controlling for CPZ
equivalents was obtained by first regressing trialwise errors as CPZ-dependent
effects excluding random effects to not absorb variance related to the experimental
group that subjects belonged to (notice dropped m subscripts):
θen ¼ β0 þ β1CPZn þ β2;dCPZndelayn  β3CPZnDoGðθdnÞ
 β4;dCPZndelaynDoGðθdnÞ þ εn
ð6Þ
and subsequently modeling residuals εn as main and interaction effects of group,
delay, and DoG(θdnm) as described in Eq. (1) (Supplementary Fig. 9g–l).
Biases towards stimuli in trial n− 2 were measured by including distances to
the penultimate stimulus, θd0nm ’
θenm ¼ β0 þ β1;ggroupnm þ β2;ddelaynm  β3DoGðθdnmÞ
þ β4;g;dgroupnmdelaynm  β5;ggroupnmDoGðθdnmÞ
 β6;ddelaynmDoGðθdnmÞ  β7;g;dgroupnmdelaynmDoGðθdnmÞ
 β8DoGðθd0nmÞ  β9;ggroupnmDoGðθd0nmÞ  β10;ddelaynmDoGðθd0nmÞ
 β11;g;dgroupnmdelaynmDoGðθd0nmÞ þ γ0;m  γ1;mDoGðθdnmÞ
 γ2;m;ddelaynmDoGðθdnmÞ þ εnm
ð7Þ
Baseline and follow-up sessions in encephalitis patients and controls were
compared by:
θen ¼ β0 þ β1sessionn þ β2;ggroupn þ β3;ddelayn
 β4DoGðθdnÞ þ β5;g sessionngroupn þ β6;dsessionndelayn
þ β7;g;dgroupndelayn  β8sessionnDoGðθdnÞ
 β9;ggroupnDoGðθdnÞ  β10;ddelaynDoGðθdnÞ
 β11;g sessionngroupnDoGðθdnÞ  β12;dsessionndelaynDoGðθdnÞ
 β13;g;dgroupndelaynDoGðθdnÞ  β14;g;dsessionngroupndelaynDoGðθdnÞ þ εn
ð8Þ
where sessionn takes values 0 or 1 (baseline vs. follow-up). In this model, we did
not include random effects due to increased model complexity and resulting
difficulties in model convergence. For extended linear models in Eqs. (4), (5), (7),
and (8), we compared nested models via Wald Tests to determine the optimal
model complexity. Data was analyzed in Python 3.7. We used different packages
from R statistics (version 3.6.3) through the ‘rpy2’ interface64. All linear mixed
models were fitted, compared and statistically tested with packages ‘lme4’65 and
‘lmerTest’66, which calculates ANOVA tables for the fixed effects of the linear
mixed model by estimating degrees of freedom and F values using Satterthwaite’s
method. For optimization, we used the ‘optimx’ package67 ‘nlimb’ algorithm with a
convergence tolerance of 0.003 and checked the consistency of parameter estimates
with other optimization algorithms (‘L-BFGS-B’, ‘bobyqa’). Note that the normality
assumption of residuals was not met (normality test, s2+ k2= 4248.72, p < 1e−16),
but with only slightly diverting kurtosis (Fisher)= 3.37 and skewness= 0.12
parameters. Due to the large number of trials (n= 52,394), this should not
compromise statistical inference68. Moreover, all effects of relevant task variables
are visualized both in a model-based and model-free way to confirm their
congruence.
Basis function selection and hyperparameter cross-validation. To determine
the hyperparameter σ used in Eqs. (1)–(8), we fitted errors θen in trial n as a linear
model including factors group, delay, and DoG(θdn) as described in Eq. (1), but
excluding random effects:
θen ¼ β0 þ β1;ggroupn þ β2;ddelayn  β3DoGðθdnÞ
þ β4;g;dgroupndelayn  β5;ggroupnDoGðθdnÞ
 β6;ddelaynDoGðθdnÞ  β7;g;dgroupndelaynDoGðθdnÞ þ εn
ð9Þ
while setting Gaussian hyperparameters μ= 0 and σ 2 ½0:2; 1:8 (in radians). For
each value of the scale parameter σ, we used a stratified cross-validation procedure,
fitting the linear model to 67% of the trials from each subject and testing the
prediction in the left-out 33% of trials. Performance for each σ was evaluated using
the mean squared error (MSE) of predictions from 1000 cross-validation repeti-
tions. σ was chosen so as to minimize the MSE obtained by the linear model,
yielding σ= 0.8 (Supplementary Fig. 1).
To test whether a linear model with repulsive biases at high distances jθdnj fitted
our data more parsimoniously, we compared cross-validation MSE for linear
models with first- and third-derivative-of-Gaussian basis functions (Supplementary
Fig. 1). We repeated the hyperparameter fitting procedure described above for the
third-derivative-of-Gaussian model using hyperparameters μ= 0 and σ 2 ½0:6; 2:0
rad. As the first-derivative-of-Gaussian model produced smaller MSE in the cross-
validation procedure, we discarded the third-derivative-of-Gaussian model. Thus,
all linear model results reported in this manuscript correspond to the first-
derivative-of-Gaussian model.
Confidence intervals and effect sizes. We compared single-subject bias estimates
between groups using post hoc t-tests. Effect sizes for these comparisons were
estimated as Cohen’s d, defined as d ¼ μ1μ2s for independent samples, where s is





, and as d ¼ tffiffinp for related
samples. For correlations of individual subjects’ biases with symptoms, we used
Pearson correlation and calculated parametric 95% confidence intervals (‘CIr’
function from the ‘psychometric’69 package). In the face of small, potentially non-
normal samples, we confirmed significant results with bootstrap confidence
intervals and p-values, leading to consistent results in all but one correlation
(Supplementary Fig. 10g): Here, we obtained C.I= [−0,83, −0,02] and p= 0.04
with parametric methods, but C.I.= [−0.85, 0.09] and p= 0.09 with non-
parametric methods (all two-sided; note however that our directed hypothesis of an
expected negative correlation supports a one-sided test with p= 0.04). Confidence
intervals of the mean (Figs. 1 and 3, and Supplementary Figs. 5, 6 and 9) were
calculated as 95% bootstrap confidence intervals.
Neural network architecture and dynamics. We simulated consecutive pairs of
trials in a spiking neural network model of prefrontal cortex implemented in
Brian270. NE= 1024 excitatory and NI= 256 inhibitory leaky integrate-and-fire
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neurons were connected all-to-all via synapses governed by NMDAR-, AMPAR-,
and GABAAR-dynamics, as described in ref. 21.





















sGj ðVi  EGÞ  gext;EsextðVi  EAÞ þ Isi
ð10Þ
with membrane capacitance Cm ¼ 0:5 nF, leak conductance gL ¼ 25 nS, leak
reversal potential EL ¼ 70mV, AMPAR, GABAAR and NMDAR reversal
potentials EA ¼ 0mV, EG ¼ 70mV, EN ¼ 0mV, unitary conductances
gext;E ¼ 3:1 nS, gIE ¼ 2:672 nS, gEE;N ¼ 0:56 nS, gEE;A ¼ 0:502 nS, and the NMDAR
magnesium block parameter a ¼ 0:062mV1. In simulations of reduced NMDAR
conductance, parameters gEE;N or respectively gEI;N were modulated as indicated in
Fig. 3b, c, e, f and Supplementary Fig. 14.
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XNE
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sGj ðVj  EGÞ  gext;I sextðVi  EAÞ
ð11Þ
with Cm ¼ 0:2 nF, gL ¼ 20 nS, gext;I ¼ 2:38 nS, gII ¼ 2:048 nS, gEI;A ¼ 0:384 nS and
gEI;N ¼ 0:424 nS.









δðt  tiÞ ð12Þ
with τA ¼ 2ms, τG ¼ 10ms, τext ¼ 2ms, and the summation running over all
spike times ti so that at each spike time the synaptic variable increased by a step of
magnitude w, which was generally set to 1 except for synapses undergoing synaptic
potentiation (see below). For sext, spike times were generated as a Poisson spike
train of rate 1800 spikes s−1 (simulating inputs from 1000 external Poisson neurons
firing at 1.8 spikes s−1 each).
















δðt  tjÞ ð14Þ
with τNs ¼ 100 ms, τNx ¼ 2 ms, and αN ¼ 0:5 kHz.
The strength of recurrent excitatory synapses was modulated depending on the
distance in preferred location of presynaptic and postsynaptic excitatory neurons:
WEEij ¼ Jðθi  θjÞ, where J is a Gaussian function (centered at μ= 0 with σ= 14.4
degrees) plus a constant, tuned so that
P
j
Jðθi  θjÞ ¼ NE and J(0)= 1.63. As a
result, neurons with similar preferred locations had 1.63 stronger weights than the
average weight (Supplementary Fig. 10 for network scheme and weight profiles).
STP rule in neural network simulations. For connections between excitatory
neurons, the spike-triggered step in AMPAR and NMDAR synaptic variables w
could vary individually for each specific connection: wij characterized the step at
the synapse from neuron j onto neuron i. Upon synchronized pre- and post-
synaptic spiking, wij was slightly enhanced by an amount Δw that depended on the
relative spike times of neuron j and i (Fig. 2c) to simulate an increase in probability
of glutamate release71:
wij ¼ wij þ Δwðtj  tiÞ≥ 1 ð15Þ
The associative nature of this rule was determined by a potentiation function
that required synchronization within a specific temporal window (Fig. 2d):
Δwðtj  tiÞ ¼ P exp jtj  tij=τΔ
 
; ð16Þ
with potentiation factor P= 0.00022 and τΔ= 20 ms. Changes were sustained (did
not decay with time), but synapses depotentiated based on presynaptic activity3: at
each presynaptic spike
wij ¼ wij  0:04*ðwij  1Þ ð17Þ
Trial structure in neural network simulations. We simulated 20,000 pairs of
consecutive trials with independent randomized stimulus locations. Network
inputs θsn in trial n with stimulus s were slightly transformed to mimic a repulsive
baseline bias away from previous stimulus locations, resulting from sensory
aftereffects produced in lower-level cortical areas29: θs0n ¼ θsn þ 1:25DoGðθdnÞ,
where DoG(θdn) is the first-derivative-of-Gaussian function with μ= 0 and σ= 0.8
radians, and θdn is the distance between previous and current stimulus.
Simulations started with a stimulus presentation at 0° (trial n− 1) for 0.25 s.
After the input was removed, a delay of 1 s followed. A negative input to the whole
network during 0.25 s simulated the response and removed stimulus-associated
neural activity. After an ITI of 3 s, a second stimulus (trial n) was delivered at a
random location for 0.25 s. The second delay duration was 3 s. To obtain behavioral
readouts from the network, we counted each neuron’s spikes during three time
windows of 0.25ms: 0–0.25 s after stimulus offset (0 s delay condition), 0.75–1 s (1 s
delay), and 2.75–3 s after stimulus offset (3 s delay). The behavioral response was
determined as the angular direction of the population vector of spike counts.
Neural network behavioral analysis. We first calculated the percentage of outlier
responses and excluded outlier trials from the network’s population vector
responses (response error >1 radian). Circular standard deviations and serial
dependence were then calculated from the network’s population vector responses
analogous to human error analyses. In Fig. 3a–f, bias strength was measured as the
sum of bias term coefficients in the linear model
θen ¼ β0 þ β1;ddelayn  β2DoGðθdnÞ  β3;ddelaynDoGðθdnÞ þ εn ð18Þ
that fitted errors θen in trial n from each parameter manipulation (P, gEE, and gEI)
separately as a function of delay and DoG(θdn) with μ= 0 and σ= 0.6 radians.
Hyperparameter cross-validation for neural network responses. The value of
hyperparameter σ was determined in a cross-validation procedure for the baseline
condition with P= 0.00022, gEE= 0.56 nS, and gEI= 0.424 nS, for values σ 2
½0:2; 1:8 (in radians). For each value of σ, we fitted the linear model described in
Eq. (18) to 67% of trials and tested the prediction in the left-out 33% of trials.
Performance for each σ was evaluated using the mean squared error (MSE) of
predictions from 1000 cross-validation repetitions. σ was chosen to minimize the
MSE of the linear model, yielding σ= 0.6 radians (Supplementary Fig. 13).
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
Behavioral data analyzed in this article are openly available by accessing the github
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